Results for tag: "Congenital Heart Defect Device"

The Congenital Heart Defect Device market is a subset of the Cardiovascular Devices market, which includes a range of medical devices used to diagnose, treat, and monitor cardiovascular diseases. Congenital Heart Defect Devices are used to treat congenital heart defects, which are structural abnormalities of the heart present at birth. These devices are used to repair or replace damaged heart valves, close holes in the heart, and provide support to weakened heart muscles. They can also be used to treat arrhythmias, or abnormal heart rhythms. The Congenital Heart Defect Device market is composed of a variety of products, including catheters, stents, occluders, and cannulae. These devices are used in a variety of procedures, such as balloon valvuloplasty, atrial septal defect closure, and ventricular septal defect closure. Some of the major companies in the Congenital Heart Defect Device market include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, and St. Jude Medical, Inc. Show Less Read more